MGO One Seven LLC Purchases New Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

MGO One Seven LLC acquired a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 24,760 shares of the pharmacy operator’s stock, valued at approximately $231,000.

A number of other institutional investors and hedge funds have also made changes to their positions in WBA. First Financial Corp IN grew its stake in shares of Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after buying an additional 885 shares during the last quarter. Golden State Wealth Management LLC bought a new stake in Walgreens Boots Alliance in the fourth quarter worth $26,000. Riverview Trust Co grew its stake in shares of Walgreens Boots Alliance by 123.8% in the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock worth $27,000 after acquiring an additional 1,590 shares during the last quarter. Venturi Wealth Management LLC purchased a new position in shares of Walgreens Boots Alliance in the 4th quarter worth about $28,000. Finally, Independence Bank of Kentucky bought a new position in Walgreens Boots Alliance in the 4th quarter worth about $39,000. Institutional investors own 58.59% of the company’s stock.

Insider Buying and Selling at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Chairman Stefano Pessina acquired 832,258 shares of the company’s stock in a transaction on Sunday, April 27th. The stock was acquired at an average cost of $11.01 per share, with a total value of $9,163,160.58. Following the purchase, the chairman now directly owns 145,621,079 shares of the company’s stock, valued at approximately $1,603,288,079.79. This represents a 0.57 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. 17.50% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several brokerages have issued reports on WBA. Deutsche Bank Aktiengesellschaft cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and decreased their target price for the stock from $11.00 to $9.00 in a report on Friday, February 28th. Evercore ISI upped their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research report on Monday, January 13th. Royal Bank of Canada lifted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a report on Wednesday, January 15th. Bank of America increased their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research report on Monday, January 13th. Finally, Truist Financial decreased their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research report on Friday, January 31st. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $10.59.

Walgreens Boots Alliance Stock Performance

NASDAQ:WBA opened at $10.93 on Wednesday. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $18.83. The stock has a 50-day moving average price of $10.96 and a 200 day moving average price of $10.24. The stock has a market capitalization of $9.45 billion, a P/E ratio of -1.07, a P/E/G ratio of 1.31 and a beta of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.10. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company had revenue of $38.59 billion during the quarter, compared to analysts’ expectations of $37.90 billion. During the same period last year, the company posted $1.20 earnings per share. Walgreens Boots Alliance’s quarterly revenue was up 4.1% on a year-over-year basis. Equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.